Thats news to me... but I see it as an option to do a dual trial...

Thats news to me... but I see it as an option to do a dual trial with TETA and Paxalisib maybe? As far as a risk; no. It is in early discovery or trials and will still need research to get as far as we are now. This does seem to me that KZIA has to stay on the ball and try to submit an application for approval soon. We have the voucher and they don't. Timing is everything. Even if both drugs work. First one to the table eats. Just my opinion of course. With our drug (that works) plus any other drug that may work together with it..... I see little risk here. There are other drugs and there will be more drugs. Time to FDA approval is what matters.